UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 518

Sortiert nach

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

The New England journal of medicine, 2012-04, Vol.366 (14), p.1275-1286

2012

Volltextzugriff (PDF)

Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

Nature structural & molecular biology, 2015-07, Vol.22 (7), p.522

2015

Volltextzugriff (PDF)

Guidelines for the Management of Extremely Premature Deliveries: A Systematic Review

Pediatrics (Evanston), 2015-08, Vol.136 (2), p.343

2015

Volltextzugriff (PDF)

Meditation in the Workplace: Does Mindfulness Reduce Bias and Increase Organisational Citizenship Behaviours?

Frontiers in psychology, 2022-04, Vol.13, p.747983-747983

2022

Volltextzugriff (PDF)

Connecting community college students to primary sources in the archives

College & undergraduate libraries, 2021-01, Vol.28 (1), p.119-127

2021

Volltextzugriff (PDF)

Scientific writing development: Improve DNP student skill and writing efficiency

Nurse education today, 2022-05, Vol.112, p.105334-105334, Article 105334

2022

Volltextzugriff (PDF)

Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes

PloS one, 2010-04, Vol.5 (4), p.e10254

2010

Volltextzugriff (PDF)

Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals

Virology (New York, N.Y.), 2012-06, Vol.427 (2), p.198-207

2012

Volltextzugriff (PDF)

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials

Scientific reports, 2018-01, Vol.8 (1), p.542-542, Article 542

2018

Volltextzugriff (PDF)

Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7849-7856

2005

Volltextzugriff (PDF)

Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens

Structure (London), 2009-11, Vol.17 (11), p.1538-1546

2009

Volltextzugriff (PDF)

Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D

Structure (London), 2004-02, Vol.12 (2), p.193-204

2004

Volltextzugriff (PDF)

Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure

PloS one, 2011-12, Vol.6 (12), p.e27780-e27780

2011

Volltextzugriff (PDF)

Thermodynamic Signatures of the Antigen Binding Site of mAb 447–52D Targeting the Third Variable Region of HIV‑1 gp120

Biochemistry (Easton), 2013-09, Vol.52 (36), p.6249-6257

2013

Volltextzugriff (PDF)

Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

Molecular immunology, 2009-02, Vol.46 (5), p.917-926

2009

Volltextzugriff (PDF)

Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles

Journal of Virology, 2005-04, Vol.79 (8), p.5232-5237

2005

Volltextzugriff (PDF)

Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals

Virology (New York, N.Y.), 2013-05, Vol.439 (2), p.81-88

2013

Volltextzugriff (PDF)

Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject

PloS one, 2012-06, Vol.7 (6), p.e39534-e39534

2012

Volltextzugriff (PDF)

Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1

Journal of Virology, 2006-07, Vol.80 (14), p.6865-6872

2006

Volltextzugriff (PDF)

Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

Journal of Virology, 2002-09, Vol.76 (18), p.9035-9045

2002

Volltextzugriff (PDF)

The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope

Journal of Virology, 2004-03, Vol.78 (5), p.2394-2404

2004

Volltextzugriff (PDF)

Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies

PloS one, 2011-02, Vol.6 (2), p.e17253-e17253

2011

Volltextzugriff (PDF)

1 – 25 von 518

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(383)
Mit Volltextzugriff
(424)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(518)
Japanisch
(40)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Life Sciences & Biomedicine
(215)
Humans
(209)
Female
(116)
Male
(106)
Adult
(79)
Middle Aged
(64)
Infectious Diseases
(57)
Biological And Medical Sciences
(55)
Aged
(47)
Medical Sciences
(46)
Hiv
(45)
Immunology
(43)
Human Immunodeficiency Virus
(42)
Hiv-1 - Immunology
(36)
Microbiology
(36)
Social Sciences
(35)
Virology
(32)
Adolescent
(30)
Hiv Envelope Protein Gp120 - Immunology
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

Guidelines for the Management of Extremely Premature Deliveries: A Systematic Review

Meditation in the Workplace: Does Mindfulness Reduce Bias and Increase Organisational Citizenship Behaviours?

Connecting community college students to primary sources in the archives

Scientific writing development: Improve DNP student skill and writing efficiency

Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial

Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes

Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials

Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance

Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens

Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D

Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure

Thermodynamic Signatures of the Antigen Binding Site of mAb 447–52D Targeting the Third Variable Region of HIV‑1 gp120

Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles

Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals

Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject

Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1

Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses

The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope

Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies

Suchergebnisse filtern